Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Abstract Background Continued use of tenofovir disoproxil fumarate (TDF), an antiretroviral drug, causes renal function decline and tubular damage in individuals with HIV. While tenofovir alafenamide fumarate (TAF) may have less damaging effects, it causes weight gain and abnormal lipid metabolism....

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Kensuke Abe, Junji Imamura, Akiko Sasaki, Tomoko Suzuki, Satomi Kamio, Taku Obara, Toshihiro Ito
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2024-02-01
Seri Bilgileri:	Journal of Pharmaceutical Health Care and Sciences
Konular:	Renal function Lipid metabolism HIV Tenofovir disoproxil fumarate Tenofovir alafenamide fumarate
Online Erişim:	https://doi.org/10.1186/s40780-024-00336-y
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!